Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Metry%2C+Andrew%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Metry%2C+Andrew%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Metry%2C+Andrew%22&type=Person&sort=year
PubPharm (19)
1
Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of Duchenne Muscular Dystrophy in Egypt
enthalten in:
Value in health regional issues
| 2023
von
Shehata, Z.
|
Metry, A.
|
Rabea, H.
| +3
Wird geladen...
2
Cost-effectiveness of therapeutics for COVID-19 patients : a rapid review and economic analysis
enthalten in:
Health technology assessment (Winchester, England)
| 2023
von
Metry, A.
|
Pandor, A.
|
Ren, S.
| +5
Wird geladen...
3
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis
in:
Health Technology Assessment
| 2023
von
Metry Andrew
|
Pandor Abdullah
|
Ren Shijie
| +5
Wird geladen...
4
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
enthalten in:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
| 2022
von
Rafia, R.
|
Martyn-St James, M.
|
Harnan, S.
| +3
CommentIn: Value Health. 2022 May;25(5):697-698. - PMID 35315330
Wird geladen...
5
Correction to : Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
ErratumFor: Pharmacoeconomics. 2021 Aug;39(8):913-927. - PMID 33900585
Wird geladen...
6
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion : The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
ErratumIn: Pharmacoeconomics. 2021 Jun 19;:. - PMID 34148190
Wird geladen...
7
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response : A Review of UK Studies
enthalten in:
PharmacoEconomics
| 2021
von
Duarte, A.
|
Walker, S.
|
Metry, A.
| +3
Wird geladen...
8
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies
enthalten in:
PharmacoEconomics
| 2021
von
Duarte, A.
|
Walker, S.
|
Metry, A.
| +3
Wird geladen...
9
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies
enthalten in:
PharmacoEconomics
| 2021
von
Duarte, A.
|
Walker, S.
|
Metry, A.
| +3
Wird geladen...
10
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
enthalten in:
PharmacoEconomics
| 2021
von
Pennington, B.
|
Alshreef, A.
|
Flight, L.
| +12
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
19
Aufsätze
16
E-Artikel
16
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
12
PharmacoEconomics
4
Health technology assessment (Winchester, England)
1
Health Technology Assessment
1
Value in health : the journal of the Internatio...
1
Value in health regional issues
Alle anzeigen ...
weniger ...
Thema
8
Journal Article
7
Research Support, Non-U.S. Gov't
4
COST-EFFECTIVENESS
4
COVID-19
3
cost-effectiveness
2
15C2VL427D
2
2S9ZZM9Q9V
2
Angiogenesis Inhibitors
2
Bevacizumab
2
COST-BENEFIT ANALYSIS
2
DIAGNOSTIC TESTS
2
EC 2.7.10.1
2
Randomized Controlled Trial
2
Ranibizumab
2
Receptors, Vascular Endothelial Growth Factor
2
Recombinant Fusion Proteins
2
Review
2
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
2
ZL1R02VT79
2
aflibercept
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2023
1
2022
15
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
19
Englisch
Haven't found what you're looking for?
Wird geladen...